Status:
COMPLETED
ID-Cap System Under Direct Observation
Lead Sponsor:
EtectRX, Inc.
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The ID-Cap System is classified as an ingestion event marker (IEM), a Class II medical device. The system is intended to record time-stamped ingestions with the ingestible sensor, ID-Tag which transmi...
Eligibility Criteria
Inclusion
- Stratification for gender and Body Mass Index is performed.
- The BMI-Gender categories will be: Normal/Underweight (BMI\<25), Overweight (BMI 25.0 to \<30), and Obese (BMI\>30.0); and Male/Female.
- Men and women 18 years of age or older.
- Enroll at least one subject and less than four subjects 65 years of age or older
- Enroll at least one subject and less than four subjects 18 to 21 years of age
- For females of childbearing potential, negative urine pregnancy test at time of entry and assurance that a medically-accepted means of contraception will be used for the duration of the study. Able and willing to provide informed consent.
- Willing to adhere to all protocol requirements and study procedures.
- Adequate organ function at screening (defined for investigator in protocol)
Exclusion
- Unable to take oral medications.
- Women who are pregnant, breast-feeding, or plan to become pregnant during the study, and females of childbearing potential who are not using a medically-accepted means of contraception.
- Medical condition which may affect passage through the gastrointestinal tract
- Known hypersensitivity to any component of the ingestible ID-Capsule
- Significant medical condition, psychiatric condition, current alcohol or drug abuse, or other condition which may preclude the study participant from being able to follow study procedures or to safely participate in the opinion of the investigator..
- Participation in an investigational product study (e.g., medical device or drug study) within 30 days prior to screening, or prior participation in an Ingestion Event Marker study.
- Presence of an active implantable electronic medical device.
- Positive screen for drugs of abuse (detection of drug for which a valid prescription exists is not exclusionary)
Key Trial Info
Start Date :
March 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2018
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03475485
Start Date
March 22 2018
End Date
June 1 2018
Last Update
June 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quotient Sciences
Jacksonville, Florida, United States, 32256